Longevity Acquisition Corporation (LOAC) Shareholders Approve 4D pharma Deal

4dpharma

Longevity Acquisition Corporation (LOAC) Shareholders Approve 4D pharma Deal

Longevity Acquisition Corporation (NASDAQ:LOAC) announced that its shareholders unanimously approved its combination with biotechnology firm 4D pharma plc (AIM:DDDD) at a special meeting held March 17. The combined entity is expected to have its first American Depositary Shares trading on the Nasdaq beginning Monday, March 22. In a separate move, 4D also announced a $24
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.